Chronic Myelogenous Leukemia
Showing NaN - NaN of 9
CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)
Recruiting
- CML
- +3 more
- Asciminib add-on
- +3 more
-
Augusta, Georgia
- +46 more
Jan 23, 2023
Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
-
Chicago, Illinois
- +87 more
Jan 20, 2023
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Fayetteville, Arkansas
- +22 more
Jun 29, 2021
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial
Completed
- Chronic Myelogenous Leukemia
- +3 more
-
Duarte, California
- +100 more
Jun 8, 2021
Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),
Completed
- Acute Leukemia
- +8 more
- Tacrolimus (ARM with Methotrexate)
- +7 more
-
Duarte, California
- +29 more
Jan 2, 2019
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)
Terminated
- Acute Myelogenous Leukemia
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 16, 2016
Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))
Completed
- Chronic Myelogenous Leukemia
- imatinib mesilate
- +2 more
-
Birmingham, Alabama
- +162 more
Aug 7, 2013
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Completed
- Chronic Myelogenous Leukemia
-
Birmingham, Alabama
- +69 more
Apr 13, 2011